IFP Advisors’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15
Closed -$356 3401
2023
Q3
$356 Buy
+15
New +$282 ﹤0.01% 3141
2023
Q1
Sell
-100
Closed -$13K 4572
2022
Q4
$13K Buy
100
+6
+6% +$116 ﹤0.01% 3237
2022
Q3
$5K Buy
94
+64
+213% +$1.11K ﹤0.01% 4076
2022
Q2
$3K Hold
30
﹤0.01% 4054
2022
Q1
$3K Sell
30
-5,949
-99% -$114K ﹤0.01% 4054
2021
Q4
$106K Buy
+5,979
New +$96K ﹤0.01% 1245
2019
Q1
Sell
-15
Closed 3595
2018
Q4
$0 Hold
15
﹤0.01% 3943
2018
Q3
$0 Hold
15
﹤0.01% 4063
2018
Q2
$0 Hold
15
﹤0.01% 4106
2018
Q1
$0 Hold
15
﹤0.01% 3858
2017
Q4
$0 Sell
15
-100
-87% -$1.44K ﹤0.01% 4166
2017
Q3
$2K Sell
115
-300
-72% -$4.84K ﹤0.01% 3817
2017
Q2
$7K Buy
415
+300
+261% +$4.56K ﹤0.01% 3254
2017
Q1
$2K Buy
115
+15
+15% +$221 ﹤0.01% 3714
2016
Q4
$1K Hold
100
﹤0.01% 3872
2016
Q3
$1K Hold
100
﹤0.01% 3800
2016
Q2
$1K Buy
+100
New +$1.34K ﹤0.01% 3717
2016
Q1
Sell
-100
Closed -$2K 3587
2015
Q4
$2K Buy
+100
New +$1.46K ﹤0.01% 3388

Other funds holding NXGN

IFP Advisors's NXGN Position: Q4 2023 in Review

IFP Advisors sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 15 shares — an estimated $356 sold.

IFP Advisors first reported a position in NXGN in Q4 2015 and held it in 18 quarters. The position peaked at $106K in Q4 2021. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • IFP Advisors reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • IFP Advisors sold 15 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $356.
  • IFP Advisors first reported a position in NextGen Healthcare, Inc. Common Stock in Q4 2015 and held it in 18 quarters.
  • IFP Advisors's NextGen Healthcare, Inc. Common Stock position peaked at $106K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on IFP Advisors's 13F filing for Q4 2023, filed 9 Jan 2024.